vs

Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -26.0%, a 13.4% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -23.3%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $-9.2M). Over the past eight quarters, CBAK Energy Technology, Inc.'s revenue compounded faster (-0.0% CAGR vs -20.9%).

CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

CBAT vs PETS — Head-to-Head

Bigger by revenue
CBAT
CBAT
1.4× larger
CBAT
$58.8M
$40.7M
PETS
Growing faster (revenue YoY)
CBAT
CBAT
+155.0% gap
CBAT
131.8%
-23.3%
PETS
Higher net margin
CBAT
CBAT
13.4% more per $
CBAT
-12.5%
-26.0%
PETS
More free cash flow
CBAT
CBAT
$25.3M more FCF
CBAT
$16.1M
$-9.2M
PETS
Faster 2-yr revenue CAGR
CBAT
CBAT
Annualised
CBAT
-0.0%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CBAT
CBAT
PETS
PETS
Revenue
$58.8M
$40.7M
Net Profit
$-7.4M
$-10.6M
Gross Margin
7.3%
23.3%
Operating Margin
-13.6%
-25.7%
Net Margin
-12.5%
-26.0%
Revenue YoY
131.8%
-23.3%
Net Profit YoY
-63.6%
-1392.6%
EPS (diluted)
$-0.08
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBAT
CBAT
PETS
PETS
Q4 25
$58.8M
$40.7M
Q3 25
$60.9M
$44.4M
Q2 25
$40.5M
$51.2M
Q1 25
$34.9M
$50.8M
Q4 24
$25.4M
$52.0M
Q3 24
$44.6M
$58.0M
Q2 24
$47.8M
$66.2M
Q1 24
$58.8M
$65.1M
Net Profit
CBAT
CBAT
PETS
PETS
Q4 25
$-7.4M
$-10.6M
Q3 25
$2.7M
$-8.5M
Q2 25
$-3.1M
$-34.2M
Q1 25
$-1.6M
$-11.6M
Q4 24
$-4.5M
$-707.0K
Q3 24
$17.6K
$2.3M
Q2 24
$6.4M
$3.8M
Q1 24
$9.8M
$-5.0M
Gross Margin
CBAT
CBAT
PETS
PETS
Q4 25
7.3%
23.3%
Q3 25
8.0%
28.0%
Q2 25
11.0%
28.1%
Q1 25
13.7%
29.9%
Q4 24
13.1%
31.0%
Q3 24
15.6%
32.3%
Q2 24
26.6%
28.8%
Q1 24
31.9%
29.3%
Operating Margin
CBAT
CBAT
PETS
PETS
Q4 25
-13.6%
-25.7%
Q3 25
-6.6%
-18.9%
Q2 25
-8.7%
-66.7%
Q1 25
-8.2%
-11.9%
Q4 24
-26.0%
-0.9%
Q3 24
-1.9%
1.0%
Q2 24
12.4%
6.6%
Q1 24
17.4%
-5.9%
Net Margin
CBAT
CBAT
PETS
PETS
Q4 25
-12.5%
-26.0%
Q3 25
4.4%
-19.2%
Q2 25
-7.6%
-66.7%
Q1 25
-4.5%
-22.9%
Q4 24
-17.8%
-1.4%
Q3 24
0.0%
4.0%
Q2 24
13.5%
5.7%
Q1 24
16.7%
-7.7%
EPS (diluted)
CBAT
CBAT
PETS
PETS
Q4 25
$-0.08
$-0.50
Q3 25
$0.03
$-0.41
Q2 25
$-0.03
$-1.65
Q1 25
$-0.02
$-0.56
Q4 24
$-0.05
$-0.03
Q3 24
$0.00
$0.11
Q2 24
$0.07
$0.18
Q1 24
$0.11
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBAT
CBAT
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$8.3M
$26.9M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$112.7M
$32.8M
Total Assets
$426.2M
$88.0M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBAT
CBAT
PETS
PETS
Q4 25
$8.3M
$26.9M
Q3 25
$10.5M
$36.1M
Q2 25
$45.7M
$41.1M
Q1 25
$9.6M
$54.7M
Q4 24
$11.0M
$50.1M
Q3 24
$24.2M
$52.0M
Q2 24
$44.1M
$46.0M
Q1 24
$23.8M
$55.3M
Total Debt
CBAT
CBAT
PETS
PETS
Q4 25
$4.1M
Q3 25
$4.8M
Q2 25
$4.9M
Q1 25
$4.1M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CBAT
CBAT
PETS
PETS
Q4 25
$112.7M
$32.8M
Q3 25
$121.4M
$43.1M
Q2 25
$118.2M
$51.5M
Q1 25
$120.8M
$85.1M
Q4 24
$121.7M
$96.2M
Q3 24
$131.2M
$96.4M
Q2 24
$126.6M
$93.5M
Q1 24
$120.9M
$96.7M
Total Assets
CBAT
CBAT
PETS
PETS
Q4 25
$426.2M
$88.0M
Q3 25
$363.9M
$100.3M
Q2 25
$333.1M
$109.8M
Q1 25
$311.5M
$148.7M
Q4 24
$302.2M
$144.8M
Q3 24
$293.5M
$146.0M
Q2 24
$279.6M
$152.7M
Q1 24
$286.5M
$169.9M
Debt / Equity
CBAT
CBAT
PETS
PETS
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.03×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBAT
CBAT
PETS
PETS
Operating Cash FlowLast quarter
$29.8M
$-9.2M
Free Cash FlowOCF − Capex
$16.1M
$-9.2M
FCF MarginFCF / Revenue
27.3%
-22.7%
Capex IntensityCapex / Revenue
23.4%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$3.9M
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBAT
CBAT
PETS
PETS
Q4 25
$29.8M
$-9.2M
Q3 25
$14.6M
$-2.2M
Q2 25
$13.8M
$-12.3M
Q1 25
$-9.6M
$7.0M
Q4 24
$9.6M
$-1.2M
Q3 24
$19.7M
$7.4M
Q2 24
$2.9M
$-8.5M
Q1 24
$7.4M
$7.1M
Free Cash Flow
CBAT
CBAT
PETS
PETS
Q4 25
$16.1M
$-9.2M
Q3 25
$6.0M
$-4.8M
Q2 25
$4.1M
$-13.6M
Q1 25
$-22.3M
$4.6M
Q4 24
$3.9M
$-1.9M
Q3 24
$16.5M
$6.1M
Q2 24
$2.5M
$-9.2M
Q1 24
$-454.0K
$5.9M
FCF Margin
CBAT
CBAT
PETS
PETS
Q4 25
27.3%
-22.7%
Q3 25
9.9%
-10.8%
Q2 25
10.2%
-26.5%
Q1 25
-63.9%
9.1%
Q4 24
15.5%
-3.7%
Q3 24
37.1%
10.6%
Q2 24
5.2%
-13.9%
Q1 24
-0.8%
9.0%
Capex Intensity
CBAT
CBAT
PETS
PETS
Q4 25
23.4%
0.1%
Q3 25
14.1%
5.9%
Q2 25
23.8%
2.5%
Q1 25
36.3%
4.7%
Q4 24
22.5%
1.5%
Q3 24
7.0%
2.2%
Q2 24
0.9%
1.0%
Q1 24
13.4%
1.9%
Cash Conversion
CBAT
CBAT
PETS
PETS
Q4 25
Q3 25
5.51×
Q2 25
Q1 25
Q4 24
Q3 24
1115.72×
3.18×
Q2 24
0.46×
-2.27×
Q1 24
0.76×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBAT
CBAT

Manufacturing Lithium Batteries$28.0M48%
Residential Energy Supply And Uninterruptable Supplies$17.8M30%
Light Electric Vehicles$12.9M22%
Precursor$108.0K0%

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons